Magenta Therapeutics, Inc.
MGTA · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $23 | $58 | $132 | $58 |
| Short-Term Investments | $252 | $54 | $45 | $91 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $6 | $4 | $4 | $3 |
| Total Curr. Assets | $281 | $116 | $177 | $152 |
| Property Plant & Equip (Net) | $2 | $29 | $7 | $8 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $82 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $10 | $2 | $6 | $2 |
| Total NC Assets | $93 | $31 | $13 | $10 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $374 | $147 | $190 | $162 |
| Liabilities | – | – | – | – |
| Payables | $5 | $2 | $3 | $4 |
| Short-Term Debt | $0 | $4 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $13 | $8 | $8 | $8 |
| Total Curr. Liab. | $18 | $15 | $11 | $11 |
| LT Debt | $1 | $26 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2 | $0 | $6 | $6 |
| Total NC Liab. | $3 | $26 | $6 | $6 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $22 | $41 | $17 | $18 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$174 | -$402 | -$326 | -$254 |
| AOCI | $0 | -$0 | -$0 | -$0 |
| Other Equity | $527 | $508 | $498 | $398 |
| Total Equity | $352 | $106 | $173 | $144 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $374 | $147 | $190 | $162 |
| Net Debt | -$21 | -$28 | -$132 | -$58 |